Investigational Site Number : 6160005

Krakow, Lesser Poland Voivodeship 31-501

0 studies enrolling now · 3 studies all time

What they study most

Multiple Sclerosis, Plasma Cell Myeloma, Plasma Cell Myeloma Recurrent

Studies at this site

• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
• SC Versus IV Isatuximab in Combination With Pomalidomide and Dexamethasone in RRMM — Running, not enrolling
• Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients — Completed